Suchergebnisse - "Shi, Fengxia"

PubPharm (3)

1

2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma

enthalten in: Cancer biology & medicine | 2023

von Li, P. | Liu, Y. | Liang, Y. | +37

2

Anti-PD-1 antibodies as a salvage therapy for patients with diffuse large B cell lymphoma who progressed/relapsed after CART19/20 therapy

enthalten in: Journal of hematology & oncology | 2021

von Wang, C. | Shi, F. | Liu, Y. | +8

ErratumIn: J Hematol Oncol. 2021 Sep 23;14(1):150. - PMID 34556168

3

An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells

enthalten in: Science China. Life sciences | 2016

von Zhang, Y. | Zhang, W. | Dai, H. | +12

1
[1]